Expert interview

<5 minutes

Interplay of Barrier Dysfunction and Type 2 Inflammation in Clinical Symptoms of EoE

Topic: Burden Of Disease Pathophysiology

Tags: Disease burden  Pathophysiology  EoE  Eosinophilic Esophagitis  Expert opinion 

Interplay of Barrier Dysfunction and Type 2 Inflammation in Clinical Symptoms of EoE

Learn from Dr. Seema Aceves as she reviews how key type 2 cytokines play a critical role in barrier dysfunction and the pathophysiology of EoE and the impact on patient burden.

 

MAT-US-2111180 V1 Expiration Date 01/01/2024

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi Genzyme and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi Genzyme and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM